These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 16540035

  • 41. [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].
    Herrero P, Marín R, Fernández Vega F, Gorostidi M, Riesgo A, Vázquez J, Díez Ojeda B, Investigadores del Estudio FRESHA.
    Nefrologia; 2006; 26(3):330-8. PubMed ID: 16892821
    [Abstract] [Full Text] [Related]

  • 42. Electrocardiographic strain pattern and left ventricular diastolic function in hypertensive patients with left ventricular hypertrophy: the LIFE study.
    Palmieri V, Okin PM, Bella JN, Wachtell K, Oikarinen L, Gerdts E, Boman K, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2006 Oct; 24(10):2079-84. PubMed ID: 16957569
    [Abstract] [Full Text] [Related]

  • 43. Trends in hypertension control and left ventricular hypertrophy over three years.
    Cuspidi C, Michey I, Meani S, Severgnini B, Fusi V, Salerno M, Valerio C, Magrini F, Zanchetti A.
    Ital Heart J; 2002 Sep; 3(9):514-9. PubMed ID: 12407847
    [Abstract] [Full Text] [Related]

  • 44. Influence of the type and degree of left ventricular hypertrophy on the prevalence of ventricular arrhythmias in patients with hypertensive heart disease.
    Kunisek J, Zaputović L, Mavrić Z, Kunisek L, Bruketa-Markić I, Karlavaris R, Lukin-Eskinja K.
    Med Klin (Munich); 2008 Oct 15; 103(10):705-11. PubMed ID: 18936895
    [Abstract] [Full Text] [Related]

  • 45. Cardiovascular risk and blood pressure control in a Spanish hypertensive population attended in a Primary Care setting. Data from the PRESCAP 2006 study.
    Rodriguez-Roca GC, Llisterri-Caro JL, Barrios-Alonso V, Alonso-Moreno FJ, Lou-Arnal S, Prieto-Diaz MA, Sanchez-Ruiz T, Dura-Belinchon R, Santos-Rodriguez JA, Divison-Garrote JA, Gonzalez-Segura D, Banegas-Banegas JR, Working Group of Arterial Hypertension of the Spanish Society of Primary Care Physicians (group HTA/SEMERGEN), PRESCAP 2006 Investigators.
    Blood Press; 2009 Oct 15; 18(3):117-25. PubMed ID: 19455457
    [Abstract] [Full Text] [Related]

  • 46. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany.
    Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D.
    Pharmacoepidemiol Drug Saf; 2008 May 15; 17(5):485-94. PubMed ID: 18383562
    [Abstract] [Full Text] [Related]

  • 47. Prevalence and correlates of advanced retinopathy in a large selected hypertensive population. The Evaluation of Target Organ Damage in Hypertension (ETODH) study.
    Cuspidi C, Meani S, Valerio C, Fusi V, Catini E, Sala C, Magrini F, Zanchetti A.
    Blood Press; 2005 May 15; 14(1):25-31. PubMed ID: 15823944
    [Abstract] [Full Text] [Related]

  • 48. Microalbuminuria in patients with essential hypertension and its relationship to target organ damage: an Indian experience.
    Hitha B, Pappachan JM, Pillai HB, Sujathan P, Ramakrishna CD, Jayaprakash K, Raihanathul Misiriya KJ.
    Saudi J Kidney Dis Transpl; 2008 May 15; 19(3):411-9. PubMed ID: 18445902
    [Abstract] [Full Text] [Related]

  • 49. Prognostic implications of left ventricular hypertrophy.
    Vakili BA, Okin PM, Devereux RB.
    Am Heart J; 2001 Mar 15; 141(3):334-41. PubMed ID: 11231428
    [Abstract] [Full Text] [Related]

  • 50. Sex differences in risk factor control of treated hypertensives: a national primary healthcare-based study in Sweden.
    Journath G, Hellénius ML, Petersson U, Theobald H, Nilsson PM, Hyper-Q Study Group Sweden.
    Eur J Cardiovasc Prev Rehabil; 2008 Jun 15; 15(3):258-62. PubMed ID: 18525379
    [Abstract] [Full Text] [Related]

  • 51. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C, Barletta G, Badia T, Capalbio A, Del Bene R, Franchi F, Gensini GF, Michelucci A.
    Ital Heart J; 2005 Apr 15; 6(4):304-10. PubMed ID: 15902928
    [Abstract] [Full Text] [Related]

  • 52. [Association of cardiovascular risk factors in hypertensive patients with left ventricular hypertrophy].
    Laviades C, Mayor G, Díez J.
    Rev Clin Esp; 1991 Dec 15; 189(9):403-7. PubMed ID: 1838817
    [Abstract] [Full Text] [Related]

  • 53. Combined QT interval and voltage criteria improve left ventricular hypertrophy detection in resistant hypertension.
    Salles G, Leocádio S, Bloch K, Nogueira AR, Muxfeldt E.
    Hypertension; 2005 Nov 15; 46(5):1207-12. PubMed ID: 16203872
    [Abstract] [Full Text] [Related]

  • 54. Electrocardiographic abnormalities among dialysis naïve chronic kidney disease patients in Ilorin Nigeria.
    Chijioke A, Makusidi AM, Kolo PM.
    Ann Afr Med; 2012 Nov 15; 11(1):21-6. PubMed ID: 22199043
    [Abstract] [Full Text] [Related]

  • 55. [Prevalence of kidney insufficiency in primary care population in Spain: EROCAP study].
    de Francisco AL, De la Cruz JJ, Cases A, de la Figuera M, Egocheaga MI, Górriz JI, Llisterri JI, Marín R, Martínez Castelao A.
    Nefrologia; 2007 Nov 15; 27(3):300-12. PubMed ID: 17725449
    [Abstract] [Full Text] [Related]

  • 56. Standard electrocardiographic criteria for left ventricular hypertrophy in Nigerian hypertensives.
    Dada A, Adebiyi AA, Aje A, Oladapo OO, Falase AO.
    Ethn Dis; 2005 Nov 15; 15(4):578-84. PubMed ID: 16259479
    [Abstract] [Full Text] [Related]

  • 57. Prevalence and clinical correlates of right ventricular hypertrophy in essential hypertension.
    Cuspidi C, Negri F, Giudici V, Valerio C, Meani S, Sala C, Esposito A, Masaidi M, Zanchetti A, Mancia G.
    J Hypertens; 2009 Apr 15; 27(4):854-60. PubMed ID: 19516183
    [Abstract] [Full Text] [Related]

  • 58. Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989.
    Mosterd A, D'Agostino RB, Silbershatz H, Sytkowski PA, Kannel WB, Grobbee DE, Levy D.
    N Engl J Med; 1999 Apr 22; 340(16):1221-7. PubMed ID: 10210704
    [Abstract] [Full Text] [Related]

  • 59. [Advantages and disadvantages of ECG diagnosis in left ventricular hypertrophy].
    Cífková R.
    Vnitr Lek; 2002 Dec 22; 48 Suppl 1():103-8. PubMed ID: 12744029
    [Abstract] [Full Text] [Related]

  • 60. Left ventricular hypertrophy is present in one-half of newly-diagnosed peripheral arterial disease patients.
    Wright GA, Ang DS, Stonebridge PA, Belch JJ, Struthers AD.
    J Hypertens; 2007 Feb 22; 25(2):463-9. PubMed ID: 17211255
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.